Disagreements about what worked and what didn’t against the biggest public health disaster in modern times have yet to be ...

The No. 2 in command at the National Institutes of Health, Dr. Lawrence A. Tabak, who served as acting director of the agency ...

Since President Trump returned to the White House, federal budget cuts have been discussed nearly every day, and now, there’s ...

Faculty members share insights, expertise on the ramifications of a decline in federal support for science and research ...

Her "simple request" of pharma companies "is simply to provide products." Only a handful of pharmaceutical compounds have ...

The reelection of Donald Trump was, in many ways, a correction. A correction for how the media and government have conducted ...

Researchers say the Trump administration's plan to slash payments for indirect costs will hamper new medical science. One ...

One of Trump's top health-related nominees had an uncommon income source over the past two years: posting on social media.

The fees, which cover overhead costs, add an average of 27 percent to the cost of a grant but vary considerably. The Trump ...

Tabak led the NIH during part of the COVID-19 pandemic and faced scrutiny from congressional Republicans over federal grants provided to Manhattan-based nonprofit EcoHealth Alliance for bat ...

The country’s first line of defense against public-health threats has been spared by DOGE—for now.